OPEN-SOURCE SCRIPT
Strong Biotech Screener | ProjectSyndicate
Strong Biotech Screener turns dozens of charts into a single institutional-style dashboard, ranking a curated universe of 40 leading biotech names by performance across six timeframes and scoring each one on professional-grade risk metrics — Beta, Sharpe, Sortino, Omega, Z-Score, and Kelly — so you can find the year's biotech leaders and weigh their risk-adjusted quality at a glance, all on one clean, sortable panel. Every figure is computed live on the daily timeframe from real price history, not hard-coded, so the board reflects the market as it actually is right now.
🧬 Curated 40-Name Biotech Universe — the screener watches a hand-picked list of 40 high-momentum biotech, pharma, and life-sciences stocks in one place. Instead of flipping through forty charts, you see every name's performance and risk profile side by side and immediately spot who is leading and who is rolling over.
🗓️ Six-Timeframe Performance — each stock is tracked across Week, Month, Quarter, 6-Month, 12-Month, and Year-to-Date returns, so you can separate a one-week catalyst pop from a genuine long-run trend and see momentum building or fading across horizons in a single row.
🧮 Institutional Risk Metrics, Done Properly — beyond raw returns, every name is scored on Sharpe (excess return per unit of total volatility), Sortino (return per unit of downside risk only), Omega (probability-weighted gains versus losses above the risk-free threshold), Z-Score (how stretched the recent move is in standard deviations), and the Kelly fraction (a theoretical optimal-sizing read from return and variance). The stats are annualized from daily returns over a rolling window with a configurable risk-free rate, so the risk picture is consistent and comparable across the whole list — which matters especially in biotech, where single-name volatility is extreme.
🎯 Basket-Relative Beta — Beta is measured against an equal-weight basket of the 40 names in the screener, so it tells you how a stock moves relative to this specific biotech cohort rather than a broad index. Beta above 1 swings harder than the group; below 1 is steadier. You control the lookback length used for the beta and correlation calculation.
🌡️ Annualized Weekly Volatility — a dedicated Wk Vol column annualizes the standard deviation of recent weekly returns, giving you a fast read on how violent each name's price action is before you size into it — essential in a sector where binary trial and FDA events can move a stock 50% in a session.
🔀 Dynamic Sorting — sort the entire board by any of the six performance columns with a single setting. Rank by YTD to find the year's biotech leaders, by Week to catch what is moving on fresh catalysts, or by any horizon in between — the table re-ranks instantly.
🎨 Bloomberg-Amber Theme with Color-Coded Strength — a clean amber-on-black dashboard with a multi-level gradient that runs from bright amber on the strongest gains through to deep red on the steepest losses, so strength and weakness jump out the moment you look at the panel.
🧩 Fully Customizable Dashboard — place the table anywhere on the chart (Top / Middle / Bottom paired with Left / Center / Right), choose your text size (Tiny / Small / Normal / Large), set the sort column, the beta length, and the risk-free rate and periods — all from the settings menu, no code editing required.
🔒 Daily-Timeframe Lock — the screener is built for daily data and will prompt you to switch if you load it on a lower timeframe, so the returns, volatility, and ratios are always calculated on the basis they are designed for.
⚡ Lightweight and Efficient — the whole 40-name board is built from a tight, well-organized script that runs smoothly on TradingView, with a clean merged title heading and an alternating-row layout for easy reading. Delisted or halted tickers degrade gracefully to blank rows rather than breaking the panel.
🎯 Why this is different — most watchlists show you price and maybe a percentage move. This screener puts performance and a full institutional risk stack — Sharpe, Sortino, Omega, Z-Score, Kelly, Beta, and annualized volatility — for forty leading biotech names on one sortable, color-coded panel, so you are ranking opportunities by risk-adjusted quality, not just chasing the biggest green number.
🚀 Where to use it — apply it to any daily chart to monitor the biotech leadership group as a whole. Use it for top-down scanning, rotation ideas, and risk screening before you drill into an individual name's chart for entry timing.
⚠️ Important — this is a research and decision-support dashboard, not a buy/sell system, and it makes no performance guarantees. The 40-name universe is a snapshot of the year's momentum leaders and will drift over time; the board re-ranks live, but membership is fixed until updated. All figures are historical and descriptive, computed from past price data, and say nothing certain about the future. Risk metrics like Sharpe, Sortino, Omega, Z-Score, and Kelly are simplified, assumption-based estimates and should inform your judgment, not replace it. Biotech is an especially high-risk sector driven by binary clinical and regulatory events — always pair the screener with your own analysis and risk management.
🧬 Curated 40-Name Biotech Universe — the screener watches a hand-picked list of 40 high-momentum biotech, pharma, and life-sciences stocks in one place. Instead of flipping through forty charts, you see every name's performance and risk profile side by side and immediately spot who is leading and who is rolling over.
🗓️ Six-Timeframe Performance — each stock is tracked across Week, Month, Quarter, 6-Month, 12-Month, and Year-to-Date returns, so you can separate a one-week catalyst pop from a genuine long-run trend and see momentum building or fading across horizons in a single row.
🧮 Institutional Risk Metrics, Done Properly — beyond raw returns, every name is scored on Sharpe (excess return per unit of total volatility), Sortino (return per unit of downside risk only), Omega (probability-weighted gains versus losses above the risk-free threshold), Z-Score (how stretched the recent move is in standard deviations), and the Kelly fraction (a theoretical optimal-sizing read from return and variance). The stats are annualized from daily returns over a rolling window with a configurable risk-free rate, so the risk picture is consistent and comparable across the whole list — which matters especially in biotech, where single-name volatility is extreme.
🎯 Basket-Relative Beta — Beta is measured against an equal-weight basket of the 40 names in the screener, so it tells you how a stock moves relative to this specific biotech cohort rather than a broad index. Beta above 1 swings harder than the group; below 1 is steadier. You control the lookback length used for the beta and correlation calculation.
🌡️ Annualized Weekly Volatility — a dedicated Wk Vol column annualizes the standard deviation of recent weekly returns, giving you a fast read on how violent each name's price action is before you size into it — essential in a sector where binary trial and FDA events can move a stock 50% in a session.
🔀 Dynamic Sorting — sort the entire board by any of the six performance columns with a single setting. Rank by YTD to find the year's biotech leaders, by Week to catch what is moving on fresh catalysts, or by any horizon in between — the table re-ranks instantly.
🎨 Bloomberg-Amber Theme with Color-Coded Strength — a clean amber-on-black dashboard with a multi-level gradient that runs from bright amber on the strongest gains through to deep red on the steepest losses, so strength and weakness jump out the moment you look at the panel.
🧩 Fully Customizable Dashboard — place the table anywhere on the chart (Top / Middle / Bottom paired with Left / Center / Right), choose your text size (Tiny / Small / Normal / Large), set the sort column, the beta length, and the risk-free rate and periods — all from the settings menu, no code editing required.
🔒 Daily-Timeframe Lock — the screener is built for daily data and will prompt you to switch if you load it on a lower timeframe, so the returns, volatility, and ratios are always calculated on the basis they are designed for.
⚡ Lightweight and Efficient — the whole 40-name board is built from a tight, well-organized script that runs smoothly on TradingView, with a clean merged title heading and an alternating-row layout for easy reading. Delisted or halted tickers degrade gracefully to blank rows rather than breaking the panel.
🎯 Why this is different — most watchlists show you price and maybe a percentage move. This screener puts performance and a full institutional risk stack — Sharpe, Sortino, Omega, Z-Score, Kelly, Beta, and annualized volatility — for forty leading biotech names on one sortable, color-coded panel, so you are ranking opportunities by risk-adjusted quality, not just chasing the biggest green number.
🚀 Where to use it — apply it to any daily chart to monitor the biotech leadership group as a whole. Use it for top-down scanning, rotation ideas, and risk screening before you drill into an individual name's chart for entry timing.
⚠️ Important — this is a research and decision-support dashboard, not a buy/sell system, and it makes no performance guarantees. The 40-name universe is a snapshot of the year's momentum leaders and will drift over time; the board re-ranks live, but membership is fixed until updated. All figures are historical and descriptive, computed from past price data, and say nothing certain about the future. Risk metrics like Sharpe, Sortino, Omega, Z-Score, and Kelly are simplified, assumption-based estimates and should inform your judgment, not replace it. Biotech is an especially high-risk sector driven by binary clinical and regulatory events — always pair the screener with your own analysis and risk management.
Açık kaynak kodlu komut dosyası
Gerçek TradingView ruhuyla, bu komut dosyasının mimarı, yatırımcıların işlevselliğini inceleyip doğrulayabilmesi için onu açık kaynaklı hale getirdi. Yazarı tebrik ederiz! Ücretsiz olarak kullanabilseniz de, kodu yeniden yayınlamanın Topluluk Kurallarımıza tabi olduğunu unutmayın.
syndicate001.com
Algo systems for prop traders
Algo systems for pro gold traders
Algo Trading and Indicator Tutorials
Levels desk Gold FX NQ ES JPN225
telegram.me/aisyndicate001
Algo systems for prop traders
Algo systems for pro gold traders
Algo Trading and Indicator Tutorials
Levels desk Gold FX NQ ES JPN225
telegram.me/aisyndicate001
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, alım satım veya diğer türden tavsiye veya öneriler anlamına gelmez ve teşkil etmez. Kullanım Koşulları bölümünde daha fazlasını okuyun.
Açık kaynak kodlu komut dosyası
Gerçek TradingView ruhuyla, bu komut dosyasının mimarı, yatırımcıların işlevselliğini inceleyip doğrulayabilmesi için onu açık kaynaklı hale getirdi. Yazarı tebrik ederiz! Ücretsiz olarak kullanabilseniz de, kodu yeniden yayınlamanın Topluluk Kurallarımıza tabi olduğunu unutmayın.
syndicate001.com
Algo systems for prop traders
Algo systems for pro gold traders
Algo Trading and Indicator Tutorials
Levels desk Gold FX NQ ES JPN225
telegram.me/aisyndicate001
Algo systems for prop traders
Algo systems for pro gold traders
Algo Trading and Indicator Tutorials
Levels desk Gold FX NQ ES JPN225
telegram.me/aisyndicate001
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, alım satım veya diğer türden tavsiye veya öneriler anlamına gelmez ve teşkil etmez. Kullanım Koşulları bölümünde daha fazlasını okuyun.